Literature DB >> 20084528

Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis.

Kazuichi Okazaki1, Shigeyuki Kawa, Terumi Kamisawa, Toru Shimosegawa, Masao Tanaka.   

Abstract

As the number of patients with autoimmune pancreatitis (AIP) is increasing in Japan, practical guidelines for managing AIP need to be established. Three committees [the professional committee for developing clinical questions (CQs) and statements by Japanese specialists, the expert panelist committee for rating statements by the modified Delphi method, and the evaluating committee of moderators] were organized. Fifteen AIP specialists extracted specific clinical statements from a total of 871 articles in the literature using a PubMed search (1963-2008) and a secondary database, and developed the CQs and statements. The expert panelists individually rated these clinical statements using a modified Delphi approach in which a clinical statement receiving a median score greater than 7 on a 9-point scale from the panel was regarded as valid. The professional committee developed 13, 6, 6, and 11 CQs and statements for the concept and diagnosis, extra-pancreatic lesions, differential diagnosis and treatment, respectively. The expert panelists regarded them as valid after two-round modified Delphi approaches.After evaluation by the moderators, the Japanese clinical guidelines for AIP were established. The digest versions of the present guidelines have been published in the official journal of the Japan Pancreas Society, "Pancreas." Full versions divided into three series are scheduled to be published in the present and followings two issues in the Journal of Gastroenterology with approval of Professor Go VLW, the Editor-in-Chief of "Pancreas."

Entities:  

Mesh:

Year:  2010        PMID: 20084528     DOI: 10.1007/s00535-009-0184-x

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  70 in total

1.  [A case of autoimmune pancreatitis occurring during intravesical bacillus Calmette Guerin immunotherapy for ureteral cancer].

Authors:  Yoshio Sumida; Kazuyuki Kanemasa; Shunji Tachibana; Katsuhide Maekawa; Tomoyuki Nakano
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2003-11

2.  Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan.

Authors:  Isao Nishimori; Akiko Tamakoshi; Shigeyuki Kawa; Shigeki Tanaka; Kazuo Takeuchi; Terumi Kamisawa; Hiromitsu Saisho; Kenji Hirano; Keiya Okamura; Nobuyuki Yanagawa; Makoto Otsuki
Journal:  Pancreas       Date:  2006-04       Impact factor: 3.327

3.  Autoimmune pancreatitis: a message from Japan.

Authors:  Makoto Otsuki
Journal:  J Gastroenterol       Date:  2007-05       Impact factor: 7.527

4.  Autoimmune pancreatitis in young patients.

Authors:  Terumi Kamisawa; Tokio Wakabayashi; Norio Sawabu
Journal:  J Clin Gastroenterol       Date:  2006-10       Impact factor: 3.062

Review 5.  Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis.

Authors:  K Yoshida; F Toki; T Takeuchi; S Watanabe; K Shiratori; N Hayashi
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

6.  Histopathologic characteristics of autoimmune pancreatitis based on comparison with chronic pancreatitis.

Authors:  Koichi Suda; Masaru Takase; Yuki Fukumura; Kanako Ogura; Akiko Ueda; Takaharu Matsuda; Fujihiko Suzuki
Journal:  Pancreas       Date:  2005-05       Impact factor: 3.327

7.  Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Hirotaka Ohara; Hitoshi Sano; Shigeru Aoki; Shinya Kobayashi; Tetsu Okamoto; Hideto Imai; Tomoyuki Nomura; Takashi Joh; Makoto Itoh
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

8.  Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis.

Authors:  Tetsuhide Ito; Ken Kawabe; Yoshiyuki Arita; Terumasa Hisano; Hisato Igarashi; Akihiro Funakoshi; Toshihiko Sumii; Takeharu Yamanaka; Ryoichi Takayanagi
Journal:  Pancreas       Date:  2007-03       Impact factor: 3.327

9.  IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Yasunori Sato; Koichi Tsuneyama; Joji Haratake; Hiroshi Kurumaya; Kazuyoshi Katayanagi; Shinji Masuda; Hideki Niwa; Hideo Morimoto; Atsuo Miwa; Akio Uchiyama; Bernard C Portmann; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

10.  Ultrasonographic evaluation in patients with autoimmune-related pancreatitis.

Authors:  Naoko Hyodo; Takafumi Hyodo
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

View more
  23 in total

1.  Oral steroid versus steroid pulse therapy for autoimmune pancreatitis: time to introduce new weapons.

Authors:  Ahad Eshraghian; Hamed Eshraghian
Journal:  J Gastroenterol       Date:  2011-09-20       Impact factor: 7.527

2.  Reactive fibroinflammatory pseudotumor of the pancreas: report of three cases.

Authors:  Keiko Hirata; Daisuke Hashimoto; Masahiko Hirota; Kazuya Sakata; Hideyuki Kuroki; Takaaki Ito; Shinji Ishikawa; Tetsumasa Arita; Yasushi Yagi
Journal:  Clin J Gastroenterol       Date:  2013-01-16

3.  Autoimmune pancreatitis: multidetector-row computed tomography (MDCT) and magnetic resonance (MR) findings in the Italian experience.

Authors:  Rossella Graziani; Simona Mautone; Maria Chiara Ambrosetti; Riccardo Manfredi; Thomas J Re; Lucia Calculli; Luca Frulloni; Roberto Pozzi Mucelli
Journal:  Radiol Med       Date:  2014-03-18       Impact factor: 3.469

4.  The similarity of Type 1 autoimmune pancreatitis to pancreatic ductal adenocarcinoma with significant IgG4-positive plasma cell infiltration.

Authors:  Yuri Fukui; Kazushige Uchida; Kimi Sumimoto; Takeo Kusuda; Hideaki Miyoshi; Masanori Koyabu; Tsukasa Ikeura; Yutaku Sakaguchi; Masaaki Shimatani; Toshiro Fukui; Mitsunobu Matsushita; Makoto Takaoka; Akiyoshi Nishio; Nobuaki Shikata; Noriko Sakaida; Yoshiko Uemura; Sohei Satoi; A-Hon Kwon; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2012-10-05       Impact factor: 7.527

Review 5.  Recent concepts of autoimmune pancreatitis and IgG4-related disease.

Authors:  Kazuichi Okazaki; Kazushige Uchida; Hideaki Miyoshi; Tsukasa Ikeura; Makoto Takaoka; Akiyoshi Nishio
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 6.  A practical approach to the diagnosis of autoimmune pancreatitis.

Authors:  Luca Frulloni; Antonio Amodio; Anna Maria Katsotourchi; Italo Vantini
Journal:  World J Gastroenterol       Date:  2011-04-28       Impact factor: 5.742

Review 7.  Autoimmune pancreatitis: an update on classification, diagnosis, natural history and management.

Authors:  Raghuwansh P Sah; Suresh T Chari
Journal:  Curr Gastroenterol Rep       Date:  2012-04

Review 8.  Endoscopic retrograde pancreatography: When should we do it?

Authors:  Renáta Bor; László Madácsy; Anna Fábián; Attila Szepes; Zoltán Szepes
Journal:  World J Gastrointest Endosc       Date:  2015-08-25

9.  Inflammation increases cells expressing ZSCAN4 and progenitor cell markers in the adult pancreas.

Authors:  Shigeru B H Ko; Sakiko Azuma; Yukihiro Yokoyama; Akiko Yamamoto; Kazuhiro Kyokane; Shumpei Niida; Hiroshi Ishiguro; Minoru S H Ko
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-04-18       Impact factor: 4.052

10.  Possible involvement of Toll-like receptor 7 in the development of type 1 autoimmune pancreatitis.

Authors:  Yuri Fukui; Kazushige Uchida; Yutaku Sakaguchi; Toshiro Fukui; Akiyoshi Nishio; Nobuaki Shikata; Noriko Sakaida; Yoshiko Uemura; Sohei Satoi; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2014-07-09       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.